» Articles » PMID: 31969824

Overexpression of Krüppel-Like Factor 4 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Through C-Jun-NH2-Terminal Kinase/Epithelial-Mesenchymal Transition Signaling Pathway

Overview
Journal Front Pharmacol
Date 2020 Jan 24
PMID 31969824
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Krüppel-like factor 4 (KLF4) is a transcription factor and plays a vital role in cancer initiation and development. However, the role of Krüppel-like factor 4 in the metastasis of non-small cell lung cancer (NSCLC) is not clear. Here, we demonstrated that the expression of Krüppel-like factor 4 was significantly decreased in human non-small cell lung cancer tissues compared with that in normal tissues using Western blot. We performed immunohistochemical staining and observed the decreased expression of Krüppel-like factor 4 in human lung cancer tissues, and metastatic tumor tissues located in the trachea and main bronchus. We also found that the E-cadherin expression was decreased, while vimentin expression was increased in human NSCLC tissues and metastatic tumor tissues located in the trachea and main bronchus. Additionally, enforced expression of Krüppel-like factor 4 in mouse lungs significantly inhibited the metastasis of circulating Lewis lung carcinoma cells to the lungs by attenuating mesenchymal-epithelial transition (MET). Furthermore, cell scratch assays and Matrigel invasion assays revealed that overexpression of Krüppel-like factor 4 inhibited the migration and invasion of non-small cell lung cancer cell lines A549, H1299, H226, and H1650 cells. Moreover, overexpression of Krüppel-like factor 4 attenuated TGF-β1-induced epithelial-mesenchymal transition (EMT) in A549, and inhibited the phosphorylation of c-Jun-NH2-terminal kinase (JNK), an important pathway in metastasis in non-small cell lung cancer. Our and findings illustrate that Krüppel-like factor 4 inhibited metastasis and migration of non-small cell lung cancer, and indicate that Krüppel-like factor 4 could be a potential therapeutic target for the treatment of non-small cell lung cancer.

Citing Articles

Exosomal miR-146a-5p Derived from HSCs Accelerates Sepsis-induced Liver Injury by Suppressing KLF-4.

Sheng Z, Song H, Gao X, Shu B, You Y, Liu Z Inflammation. 2024; .

PMID: 39589633 DOI: 10.1007/s10753-024-02172-6.


TMEM176B Promotes EMT via FGFR/JNK Signalling in Development and Tumourigenesis of Lung Adenocarcinoma.

Sun P, Xia S, Yuan R, Zhang B, Wang G Cancers (Basel). 2024; 16(13).

PMID: 39001509 PMC: 11240709. DOI: 10.3390/cancers16132447.


A risk score based on polyamine metabolism and chemotherapy-related genes predicts prognosis and immune cells infiltration of lung adenocarcinoma.

Du M, Meng X, Zhou B, Song W, Shi J, Liang M J Cell Mol Med. 2024; 28(12):e18387.

PMID: 38924680 PMC: 11200130. DOI: 10.1111/jcmm.18387.


Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer.

Liu W, Wang Y, Xia L, Li J Nutrients. 2024; 16(6).

PMID: 38542707 PMC: 10975298. DOI: 10.3390/nu16060797.


Overexpression of KLF4 Suppresses Pulmonary Fibrosis through the HIF-1α/Endoplasmic Reticulum Stress Signaling Pathway.

Wei S, Qi F, Wu Y, Liu X Int J Mol Sci. 2023; 24(18).

PMID: 37762310 PMC: 10530972. DOI: 10.3390/ijms241814008.


References
1.
Yang Y, Katz J . KLF4 is downregulated but not mutated during human esophageal squamous cell carcinogenesis and has tumor stage-specific functions. Cancer Biol Ther. 2016; 17(4):422-9. PMC: 4910921. DOI: 10.1080/15384047.2016.1156260. View

2.
Li S, Huang L, Gu J, Wu J, Ou W, Feng J . Restoration of KLF4 Inhibits Invasion and Metastases of Lung Adenocarcinoma through Suppressing MMP2. J Cancer. 2017; 8(17):3480-3489. PMC: 5687162. DOI: 10.7150/jca.21241. View

3.
Blum A, Venkitachalam S, Ravillah D, Chelluboyina A, Kieber-Emmons A, Ravi L . Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer. Gastroenterology. 2019; 156(6):1761-1774. PMC: 6701681. DOI: 10.1053/j.gastro.2019.01.263. View

4.
Tian C, Yao S, Liu L, Ding Y, Ye Q, Dong X . Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma. Int J Mol Med. 2016; 39(1):47-56. PMC: 5179175. DOI: 10.3892/ijmm.2016.2812. View

5.
Yu T, Chen X, Zhang W, Liu J, Avdiushko R, Napier D . KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ. 2015; 23(2):207-15. PMC: 4716302. DOI: 10.1038/cdd.2015.85. View